14 completed, 1 unknown. 15 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 14, Unknown 1 |
Follow ropinirole: new trials by email Literature Review of ropinirole trials Research Report on ropinirole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DIalysis Symptom COntrol-Restless Legs Syndrome Trial Gabapentin, Ropinirole, Placebo Gabapentin - End Stage Renal Disease, Restless Legs Syndrome | Phase 3 | Completed | Population Health Research Institute | 52 | 2019-05-01 | 2022-09-21 |
| Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists piribedil, pramipexole or ropinirole - Idiopathic Parkinson's Disease | Phase 3 | Completed | Desitin Arzneimittel GmbH | 80 | 2010-01-01 | 2012-05-24 |
| A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients SPM 962, Ropinirole, Placebo - Parkinson's Disease | Phase 3 | Completed | Otsuka Pharmaceutical Co., Ltd. | 420 | 2009-06-01 | 2014-05-23 |
| Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease ropinirole PR/XR, ropinirole IR - Parkinson Disease | Phase 3 | Completed | GlaxoSmithKline | 302 | 2009-03-01 | 2017-01-18 |
| MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist Safinamide (as add-on therapy) - Idiopathic Parkinson's Disease | Phase 3 | Completed | Newron Pharmaceuticals SPA | 679 | 2007-11-01 | 2013-10-29 |
| A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's Ropinirole prolonged release, ropinirole immediate release - Parkinson Disease | Phase 3 | Completed | GlaxoSmithKline | 343 | 2006-06-20 | 2017-08-22 |
| The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome Ropinirole - Restless Legs Syndrome, Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) | Phase 3 | Completed | GlaxoSmithKline | 240 | 2006-06-01 | 2012-06-07 |
| Pramipexole Conversion to Ropinirole Controlled Release (CR) Requip PR, Mirapex - Parkinson Disease | Phase 3 | Completed | Rajesh Pahwa, MD | 61 | 2006-01-01 | 2012-08-24 |
| Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) Ropinirole IR 1 mg, Ropinirole IR 2 mg, Ropinirole IR 1 mg Placebo - Restless Legs Syndrome, Restless Legs Syndrome (RLS) | Phase 3 | Completed | GlaxoSmithKline | 135 | 2005-11-14 | 2019-03-15 |
| Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease Ropinirole Hydrochloride - Parkinson's Disease | Phase 3 | Unknown | Agarwal, Pinky, M.D. | 20 | 2005-11-01 | 2006-02-03 |
| A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) ropinirole - Restless Legs Syndrome | Phase 3 | Completed | GlaxoSmithKline | 140 | 2005-01-01 | 2016-09-15 |
| A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome Ropinirole - Restless Legs Syndrome (RLS), Restless Legs Syndrome | Phase 3 | Completed | GlaxoSmithKline | 360 | 2003-08-01 | 2016-10-17 |
| Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa Ropinirole - Parkinson Disease | Phase 3 | Completed | GlaxoSmithKline | 393 | 2003-06-01 | 2017-03-23 |
| Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. sumanirole, ropinirole - Parkinson Disease | Phase 3 | Completed | Pfizer | 600 | 2001-12-01 | 2006-06-07 |
| Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) Lisuride, Ropinirole, Placebo - Restless Legs Syndrome | Phase 3 | Completed | Axxonis Pharma AG | 300 | 2012-03-07 |
Parkinson Disease (9) · Restless Legs Syndrome (6) · Depression (1) · Dyskinesias (1) · Fatigue (1) · Kidney Failure, Chronic (1) · Sleep Wake Disorders (1)
GlaxoSmithKline (7) · Agarwal, Pinky, M.D. (1) · Axxonis Pharma AG (1) · Desitin Arzneimittel GmbH (1) · Newron Pharmaceuticals SPA (1) · Otsuka Pharmaceutical Co., Ltd. (1) · Pfizer (1) · Population Health Research Institute (1) · Rajesh Pahwa, MD (1)
United States (8) · Germany (6) · Canada (3) · Czechia (3) · Italy (3) · Poland (3) · Spain (3) · Argentina (2) · Bulgaria (2) · France (2) · Hungary (2) · Japan (2) · Mexico (2) · South Africa (2) · Belgium (1)
Dr. Michael Walsh, PhD,FRCPC(C) (1) · Heike Benes, MD (1) · Jonathan Willmer, MD (1) · Kyoji Imaoka, Mr (1) · Martina Wangemann, Dr. (1) · Pinky Agarwal, MD (1) · Rajesh Pahwa, MD (1)